Enhanced Heme Function and Mitochondrial Respiration Promote the Progression of Lung Cancer Cells

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Hooda, Jagmohan ^a   Cadinu, Daniela ^a,c   Alam, Md Maksudul ^a   Shah, Ajit ^a   Cao, Thai M ^a   Sullivan, Laura A ^b   Brekken, Rolf ^b   Zhang, Li ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; CYTOCHROME; CYTOCHROME P450 1B1; CYTOGLOBIN; HEMOPROTEIN; MITOCHONDRIAL DNA;

ARTICLE; BIOENERGY; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; ENERGY YIELD; GLUCOSE INTAKE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LUNG CANCER; LUNG NON SMALL CELL CANCER; MITOCHONDRIAL RESPIRATION; OXYGEN CONSUMPTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY FUNCTION; WESTERN BLOTTING;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL RESPIRATION; CYTOCHROMES C; DISEASE PROGRESSION; ENERGY METABOLISM; GLUCOSE; HEME; HEMEPROTEINS; HUMANS; LUNG NEOPLASMS; MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIA; NEOPLASM PROTEINS; OXYGEN; OXYGEN CONSUMPTION; TUMOR STEM CELL ASSAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84877937674     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063402     Document Type: Article

References (64)

1. Minami S, (1923) Respiration and glycolysis. Biochem. Z. 142: 94-113.
2. Warburg O (1930) The Metabolism of Tumours. London: Constable & Co.
3. Vander Heiden MG, Locasale JW, Swanson KD, Sharfi H, Heffron GJ, et al. (2010) Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329: 1492-9.
4. Hitosugi T, Kang S, Vander Heiden MG, Chung TW, Elf S, et al. (2009) Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal 2: ra73.
5. Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang JK, et al. (2011) Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334: 1278-83.
6. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA, (2003) A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 3: 193-202.
7. DeBerardinis RJ, Thompson CB, (2012) Cellular metabolism and disease: what do metabolic outliers teach us? Cell 148: 1132-44.
8. Birsoy K, Sabatini DM, Possemato R, (2012) Untuning the tumor metabolic machine: Targeting cancer metabolism: a bedside lesson. Nat Med 18: 1022-3.
9. Jose C, Bellance N, Rossignol R, (2011) Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? Biochim Biophys Acta 1807: 552-61.
10. Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell RG, et al. (2010) Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 9: 3506-14.
11. Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, Saavedra E, (2007) Energy metabolism in tumor cells. Febs J 274: 1393-418.
12. Whitaker-Menezes D, Martinez-Outschoorn UE, Flomenberg N, Birbe RC, Witkiewicz AK, et al. (2011) Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue. Cell Cycle 10: 4047-64.
13. Kaambre T, Chekulayev V, Shevchuk I, Karu-Varikmaa M, Timohhina N, et al. (2012) Metabolic control analysis of cellular respiration in situ in intraoperational samples of human breast cancer. J Bioenerg Biomembr 44: 539-58.
14. Frezza C, Zheng L, Tennant DA, Papkovsky DB, Hedley BA, et al. (2011) Metabolic profiling of hypoxic cells revealed a catabolic signature required for cell survival. PLoS One 6: e24411.
15. Padmanaban G, Venkateswar V, Rangarajan PN, (1989) Haem as a multifunctional regulator. Trends Biochem Sci 14: 492-6.
16. Mense SM, Zhang L, (2006) Heme: a versatile signaling molecule controlling the activities of diverse regulators ranging from transcription factors to MAP kinases. Cell Res 16: 681-92.
17. Ortiz de Montellano PR (2009) Hemes in Biology. In: Wiley Encyclopedia of Chemical Biology, editors. West Sussex: John Wiley & Sons, Ltd. 240-9.
18. Andrew TL, Riley PG, Dailey HA (1990) Regulation of heme biosynthesis in higher animals. In: Biosynthesis of heme and cholorophylls, HA Dailey, editors. New York: Green Pub. Associates and Wiley-Interscience. 183-232.
19. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
20. Organization WH (2011) Cancer. Fact sheet no. 297. World Health Organization.
21. Mountain CF, (2000) The international system for staging lung cancer. Semin Surg Oncol 18: 106-15.
22. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, et al. (2004) Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 64: 9027-34.
23. Whitehurst AW, Bodemann BO, Cardenas J, Ferguson D, Girard L, et al. (2007) Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 446: 815-9.
24. Zhu Y, Hon T, Ye W, Zhang L, (2002) Heme deficiency interferes with the Ras-mitogen-activated protein kinase signaling pathway and expression of a subset of neuronal genes. Cell Growth Differ 13: 431-9.
25. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC, (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3: 187-97.
26. Shedlofsky SI, Sinclair PR, Bonkovsky HL, Healey JF, Swim AT, et al. (1987) Haem synthesis from exogenous 5-aminolaevulinate in cultured chick-embryo hepatocytes. Effects of inducers of cytochromes P-450. Biochem J 248: 229-36.
27. Pejznochova M, Tesarova M, Hansikova H, Magner M, Honzik T, et al. (2010) Mitochondrial DNA content and expression of genes involved in mtDNA transcription, regulation and maintenance during human fetal development. Mitochondrion 10: 321-9.
28. Sullivan LA, Carbon JG, Roland CL, Toombs JE, Nyquist-Andersen M, et al. (2010) r84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity induction. PLoS One 5: e12031.
29. Liang CC, Park AY, Guan JL, (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2: 329-33.
30. Pejznochova M, Tesarova M, Honzik T, Hansikova H, Magner M, et al. (2008) The developmental changes in mitochondrial DNA content per cell in human cord blood leukocytes during gestation. Physiol Res 57: 947-55.
31. De Matteis F, Marks GS, (1983) The effect of N-methylprotoporphyrin and succinyl-acetone on the regulation of heme biosynthesis in chicken hepatocytes in culture. FEBS Lett 159: 127-31.
32. Ye W, Zhang L, (2004) Heme controls the expression of cell cycle regulators and cell growth in HeLa cells. Biochem Biophys Res Commun 315: 546-54.
33. Yao X, Balamurugan P, Arvey A, Leslie C, Zhang L, (2010) Heme controls the regulation of protein tyrosine kinases Jak2 and Src. Biochem Biophys Res Commun 403: 30-5.
34. Sengupta A, Hon T, Zhang L, (2005) Heme deficiency suppresses the expression of key neuronal genes and causes neuronal cell death. Brain Res Mol Brain Res 137: 23-30.
35. Chernova T, Nicotera P, Smith AG, (2006) Heme deficiency is associated with senescence and causes suppression of N-methyl-D-aspartate receptor subunits expression in primary cortical neurons. Mol Pharmacol 69: 697-705.
36. Chernova T, Steinert JR, Guerin CJ, Nicotera P, Forsythe ID, et al. (2007) Neurite degeneration induced by heme deficiency mediated via inhibition of NMDA receptor-dependent extracellular signal-regulated kinase 1/2 activation. J Neurosci 27: 8475-85.
37. Yin L, Wu N, Curtin JC, Qatanani M, Szwergold NR, et al. (2007) Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science 318: 1786-9.
38. Wallace KB, Starkov AA, (2000) Mitochondrial targets of drug toxicity. Annu Rev Pharmacol Toxicol 40: 353-88.
39. Anderson KE, Sassa S, Bishop DF, Desnick RJ, (2009) Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: Chapter The metabolic, molecular bases of inherited disease, CR Scriver, AL Beaudt, WS Sly, D Valle, C Barton, KW Kinzler, B Vogelstein, editors. New York: The McGraw-Hill Companies, Inc. pp. 124: 1-53.
40. Anderson KE, Sassa S, Bishop DF, Desnick RJ (2001) Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: The metabolic and molecular bases of inherited disease, CR Scriver, AL Beaudt, WS Sly, D Valle, C Barton, KW Kinzler, B Vogelstein, editors. New York: The McGraw-Hill Companies, Inc. 2991-3062.
41. Zhang L, Sessoms R (2011) Heme biosynthesis and degradation: What happens when it goes haywire?. In: HEME BIOLOGY: The Secret Life of Heme in Regulating Diverse Biological Processes, L Zhang, editors. Singapore: World Scientific Publishing Company p.
42. Latunde-Dada GO, Takeuchi K, Simpson RJ, McKie AT, (2006) Haem carrier protein 1 (HCP1): Expression and functional studies in cultured cells. FEBS Lett 580: 6865-70.
43. Rajagopal A, Rao AU, Amigo J, Tian M, Upadhyay SK, et al. (2008) Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteins. Nature 453: 1127-31.
44. Khan AA, Quigley JG, (2011) Control of intracellular heme levels: heme transporters and heme oxygenases. Biochim Biophys Acta 1813: 668-82.
45. Dang TN, Bishop GM, Dringen R, Robinson SR, (2009) The putative heme transporter HCP1 is expressed in cultured astrocytes and contributes to the uptake of hemin. Glia 58: 55-65.
46. Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, et al. (2005) Identification of an intestinal heme transporter. Cell 122: 789-801.
47. Burmester T, Ebner B, Weich B, Hankeln T, (2002) Cytoglobin: a novel globin type ubiquitously expressed in vertebrate tissues. Mol Biol Evol 19: 416-21.
48. Trent JT 3rd, Hargrove MS (2002) A ubiquitously expressed human hexacoordinate hemoglobin. J Biol Chem 277: 19538-45.
49. Dang CV, (2009) PKM2 tyrosine phosphorylation and glutamine metabolism signal a different view of the Warburg effect. Sci Signal 2: pe75.
50. Guppy M, Leedman P, Zu X, Russell V, (2002) Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem J 364: 309-15.
51. Griguer CE, Oliva CR, Gillespie GY, (2005) Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines. J Neurooncol 74: 123-33.
52. Herst PM, Berridge MV, (2007) Cell surface oxygen consumption: a major contributor to cellular oxygen consumption in glycolytic cancer cell lines. Biochim Biophys Acta 1767: 170-7.
53. Zhang L (2011) HEME BIOLOGY: The Secret Life of Heme in Regulating Diverse Biological Processes. Singapore: World Scientific Publishing Company.
54. Ryter SW, Tyrrell RM, (2000) The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic Biol Med 28: 289-309.
55. Sassa S, (2004) Why heme needs to be degraded to iron, biliverdin IXalpha, and carbon monoxide? Antioxid Redox Signal 6: 819-24.
56. Frezza C, Zheng L, Folger O, Rajagopalan KN, MacKenzie ED, et al. (2011) Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature 477: 225-8.
57. Chance B, (1965) Reaction of oxygen with the respiratory chain in cells and tissues. J Gen Physiol 49Suppl: 163-95.
58. Labbe-Bois R, Labbe P (1990) Tetrapyrrole and heme biosynthesis in the yeast Sacchromyces cerevisiae. In: Biosynthesis of heme and cholorophylls, HA Dailey, editors. New York: Green Pub. Associates and Wiley-Interscience. 235-85.
59. Ogawa K, Sun J, Taketani S, Nakajima O, Nishitani C, et al. (2001) Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1. Embo J 20: 2835-43.
60. Chen JJ, London IM, (1995) Regulation of protein synthesis by heme-regulated eIF-2 alpha kinase. Trends Biochem Sci 20: 105-8.
61. de Haro C, Mendez R, Santoyo J, (1996) The eIF-2alpha kinases and the control of protein synthesis. Faseb J 10: 1378-87.
62. Faller M, Matsunaga M, Yin S, Loo JA, Guo F, (2007) Heme is involved in microRNA processing. Nat Struct Mol Biol 14: 23-9.
63. Escobar M, Velez M, Belalcazar A, Santos ES, Raez LE, (2011) The role of proteasome inhibition in nonsmall cell lung cancer. J Biomed Biotechnol 2011: 806506.
64. Sangodkar J, Katz S, Melville H, Narla G, (2010) Lung adenocarcinoma: lessons in translation from bench to bedside. Mt Sinai J Med 77: 597-605.